Drug Shortage Report for GD-ELETRIPTAN

Last updated on 2020-09-22 History
Report ID 121654
Drug Identification Number 02342243
Brand name GD-ELETRIPTAN
Common or Proper name GD-ELETRIPTAN
Company Name UPJOHN CANADA ULC
Market Status MARKETED
Active Ingredient(s) ELETRIPTAN
Strength(s) 40MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 6
ATC code N02CC
ATC description ANTIMIGRAINE PREPARATIONS
Reason for shortage Demand increase for the drug.
Anticipated start date 2020-08-17
Actual start date
Estimated end date
Actual end date 2020-09-21
Shortage status Resolved
Updated date 2020-09-22
Company comments
Health Canada comments
Contact Address 17300 TRANS CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-833-287-5646 Email / courriel: UpjohnCanadaCustomerService@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2020-09-22 English Compare
v9 2020-09-21 French Compare
v8 2020-09-21 English Compare
v7 2020-09-08 French Compare
v6 2020-09-08 English Compare
v5 2020-08-18 English Compare
v4 2020-08-07 French Compare
v3 2020-08-07 English Compare
v2 2020-08-04 French Compare
v1 2020-08-04 English Compare